Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 26, 2026 05:23 ET | Source: Research and Markets

Contract Development and Manufacturing Organization (CDMO and CMO) Market Report 2026 - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031

Dublin, Jan. 26, 2026 (GLOBE NEWSWIRE) -- The "Contract Development and Manufacturing Organization Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031" has been added...
January 19, 2026 04:01 ET | Source: Research and Markets

$15.5 Bn Next Generation Drug Conjugates Market Trends and Global Forecasts, 2035

Dublin, Jan. 19, 2026 (GLOBE NEWSWIRE) -- The "Next Generation Drug Conjugates Market: Industry Trends and Global Forecasts, Till 2035" has been added to ResearchAndMarkets.com's offering. The...
January 12, 2026 11:22 ET | Source: Research and Markets

Peptide Therapeutics Market Trends and Global Forecasts to 2040 - Investments Exceeding $7 Billion from Public and Private Sectors Reflect Burgeoning Interest and Potential Returns

Dublin, Jan. 12, 2026 (GLOBE NEWSWIRE) -- The "Peptide Therapeutics Market: Industry Trends and Global Forecasts, Till 2040 - Distribution by Type of Peptide, Route of Administration, Key...
December 05, 2025 04:03 ET | Source: Research and Markets

China's Licensing Trends Shaping Global Drug Development Analysis Report 2025: Parent Companies Benefitted from Upfront Payments for R&D, Gaining Equity in Novel Chinese Therapeutics

Dublin, Dec. 05, 2025 (GLOBE NEWSWIRE) -- The "China's Licensing Trends Shaping Global Drug Development" report has been added to ResearchAndMarkets.com's offering.Over the past five years, China's...
August 28, 2025 09:53 ET | Source: Research and Markets

Next Generation Drug Conjugates Market Report 2025-2035, with Profiles of Advanced Accelerator Applications, Alnylam Pharmaceuticals, Arrowhead, Dicerna Pharmaceuticals, Geron, & Ionis Pharmaceuticals

Dublin, Aug. 28, 2025 (GLOBE NEWSWIRE) -- The "Next Generation Drug Conjugates Market Industry Trends and Global Forecast to 2035, by Type of Next Generation Drug Conjugates, Type of Targeting...
August 13, 2025 07:48 ET | Source: Research and Markets

Antibody Drug Conjugate (ADC) Market Report 2025: Industry Set to Double by 2030 Driven by Next-Gen Oncology Innovations, Reaching $16 Billion

Dublin, Aug. 13, 2025 (GLOBE NEWSWIRE) -- The "Antibody Drug Conjugate Market by Payload Type (Auristatins, Calicheamicins, Maytansinoids), Indication (Breast Cancer, Hematological Cancer, Lung...
July 03, 2025 04:39 ET | Source: Research and Markets

State of the Biopharmaceutical Industry, Mid Year 2025 Report - Vanzacaftor Calcium + Deutivacaftor + Tezacaftor for Cystic Fibrosis is Expected to Have the Highest Commercial Success

Dublin, July 03, 2025 (GLOBE NEWSWIRE) -- The "The State of the Biopharmaceutical Industry 2025 (Mid-Year) Edition" report has been added to ResearchAndMarkets.com's offering. The report...
June 10, 2025 06:02 ET | Source: Research and Markets

Protein Drugs Analysis Report 2025-2029: Therapeutic Proteins Gain Traction for Targeted, Low-Toxicity Treatments, Competitive Landscape Intensifies as Leading Firms Expand Investments

Dublin, June 10, 2025 (GLOBE NEWSWIRE) -- The "Protein Drugs Market 2025" report has been added to ResearchAndMarkets.com's offering.The Protein Drugs Market was valued at USD 441.7 Billion in...
April 09, 2025 11:04 ET | Source: Research and Markets

High Potency Active Pharmaceutical Ingredients (HPAPI) Research Report 2025: Global Market Opportunities and Forecasts to 2034 - Adoption of Targeted Therapies and Cancer Prevalence Fueling Growth

Dublin, April 09, 2025 (GLOBE NEWSWIRE) -- The "High Potency Active Pharmaceutical Ingredients Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" report has been...
March 19, 2025 08:21 ET | Source: Research and Markets

Therapeutic Antibodies, Biosimilars & RNA Therapy Sales Report - Top-Selling Biologic Drugs & Market Trends for 2024

Dublin, March 19, 2025 (GLOBE NEWSWIRE) -- The "2024 Sales of Therapeutic Antibodies, Proteins, Biosimilars, Gene & Cell Therapy and Therapeutic RNA" report has been added to ...